Back to MORGAN STANLEY MORGAN STANLEY

HALOHALO
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in HALOZYME THERAPEUTICS INC

MORGAN STANLEY holds 2.8M shares of HALO (HALOZYME THERAPEUTICS INC), worth $221.7M as of 2026-Q2. The position was increased (+10.6% shares). HALO represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$221.7M

Current Shares

2.8M

Total Value Change

+$154.5M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.8M
+10.6%
$221.7M0.0%$78.27
34
2026-Q1
Decreased
2.6M
-3.6%
$165.6M0.0%$69.40
0
2025-Q4
Increased
2.7M
+53.0%
$178.9M0.0%$67.70
43
2025-Q3
Decreased
1.7M
-1.8%
$127.4M0.0%$73.29
0
2025-Q2
Decreased
1.8M
-8.4%
$92M0.0%$52.21
0
2025-Q1
Increased
1.9M
+17.3%
$123.2M0.0%$63.84
35
2024-Q4
Increased
1.6M
+0.7%
$78.7M0.0%$47.99
30
2024-Q3
Increased
1.6M
+27.3%
$93.6M0.0%$56.97
37
2024-Q2
New
1.3M
-
$67.2M0.0%$52.36
41

Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used